期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 59, 期 14, 页码 6739-6752出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.6b00342
关键词
-
资金
- Austrian Science Fund (FWF) [P22072-B11]
- Hungarian Research Foundation OTKA [PD103905]
- J. Bolyai Research Scholarship of the Hungarian Academy of Sciences
- Initiative Krebsforschung
- Mahlke geb. Obermann-Stiftung
One of the most promising classes of iron chelators are alpha-N-heterocyclic thiosemicarbazones with Triapine as the most prominent representative. In several clinical trials Triapine showed anticancer activity against hematological diseases, however, studies on solid tumors failed due to widely unknown reasons. Some years ago, it was recognized that terminal dimethylation of thiosemicarbazones can lead to a more than 100-fold increased activity, probably due to interactions with cellular copper depots. To better understand the structural requirements for the switch to nanomolar cytotoxicity, we systematically synthesized all eight possible N-methylated derivatives of Triapine and investigated their potential against Triapine-sensitive as well as -resistant cell lines. While only the completely methylated compound exerted nanomolar activity, the data revealed that all compounds with at least one N-dimethylation were not affected by acquired Triapine resistance. In addition, these compounds were highly synergistic with copper treatment accompanied by induction of reactive oxygen species and massive necrotic cell death.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据